Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10145 (
IL-8
)
23,849
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
C-X-C motif chemokine ligand 8 (
CXCL8
) is involved in tumor proliferation, migration, and invasion. However, the function of
CXCL8
in colorectal cancer (CRC) is controversial. Here, we analyzed RNA-sequencing (RNA-seq) data to identify differentially expressed genes and pathways according to gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways associated with CRC. The levels of the mRNA encoding
CXCL8
were significantly increased in early and advanced stages of CRC, as well as in metastases and nonmetastasis cases using RNA-seq analysis (n = 91). These findings were consistent with immunohistochemical analysis of
CXCL8
expression (n = 87). Protein-protein interaction (PPI) prediction combined with transcriptional profiling data revealed that
CXCL8
levels positively correlated with
cAMP responsive element binding protein 1
(
CREB1
)/ribosomal protein S6 kinase B1 (
RPS6KB1
) expression, which promotes cell proliferation and differentiation in high expression, while inversely correlated with the expression of Bcl2 associated agonist of cell death (
BAD
) protein to inhibit apoptosis during the progression of CRC. These findings provide compelling clinical and molecular evidence to support the conclusion that
CXCL8
contributes to the genesis and progression of CRC.
...
PMID:Transcriptional Profiling Reveals the Regulatory Role of
CXCL8
in Promoting Colorectal Cancer. 3203 15